YCH3124 exhibited strong antiproliferative activity across various cancer cell lines, inhibited the USP7 pathway, led to the accumulation of p53 and p21, disrupted cell cycle progression at G1 phase, and induced significant apoptosis, highlighting its potential as a potent anticancer agent.433. The gene discussed is TP53; the disease is cancer.